Synopsis
Synopsis
0
CEP/COS
0
VMF
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2 Amino 6 Trifluoromethoxybenzothiazole
2. 2-amino-6-trifluoromethoxybenzothiazole
3. Pk 26124
4. Pk-26124
5. Pk26124
6. Rilutek
7. Rp 54274
8. Rp-54274
9. Rp54274
1. 1744-22-5
2. Rilutek
3. 2-amino-6-(trifluoromethoxy)benzothiazole
4. 6-(trifluoromethoxy)benzo[d]thiazol-2-amine
5. 6-(trifluoromethoxy)-1,3-benzothiazol-2-amine
6. Rp-54274
7. 2-amino-6-trifluoromethoxybenzothiazole
8. 2-amino-6-(trifluoromethoxy)benzo[d]thiazole
9. 2-benzothiazolamine, 6-(trifluoromethoxy)-
10. Pk-26124
11. Rp 54274
12. Tiglutik
13. 2-amino-6-(trifluoromethoxy)-benzothiazole
14. Riluzole (rilutek)
15. Amino-2 Trifluoromethoxy-6 Benzothiazole
16. Mls000069369
17. 6-trifluoromethoxy-benzothiazol-2-ylamine
18. 2-benzothiazolamine,6-(trifluoromethoxy)-
19. Chembl744
20. Nsc-753433
21. Nsc-759823
22. Smr000058231
23. 7lj087rs6f
24. Chebi:8863
25. Riluzol
26. 2-amino-6-(trifluoromethoxy)-1,3-benzothiazole
27. Benzothiazole, 2-amino-6-trifluoromethoxy-
28. Bhv-0223
29. Ncgc00015882-09
30. Riluzolum
31. Riluzol [inn-spanish]
32. Riluzolum [inn-latin]
33. Dsstox_cid_25192
34. Dsstox_rid_80739
35. Dsstox_gsid_45192
36. C8h5f3n2os
37. Rilutek (tn)
38. Cas-1744-22-5
39. Amino-2 Trifluoromethoxy-6 Benzothiazole [french]
40. Unii-7lj087rs6f
41. 2-amino-6-(trifluoromethoxyl)benzothiazole
42. Riluzole, Solid
43. Riluzole [usan:usp:inn:ban]
44. Riluzole- Bio-x
45. Bf-37
46. Albb-006046
47. Mfcd00210213
48. Prestwick-03a08
49. Exservan
50. Pk26124
51. 6-(trifluoromethoxy)-2-benzothiazolamine
52. Tocris-0768
53. Pk 26124
54. 6-trifluoromethoxybenzothiazole-2-yl-amine
55. Opera_id_548
56. Riluzole [usan]
57. Lopac-r-116
58. Riluzole [inn]
59. Riluzole [jan]
60. Riluzole [mi]
61. Riluzole-13c-15n2
62. Prestwick0_000167
63. Prestwick1_000167
64. Prestwick2_000167
65. Prestwick3_000167
66. Spectrum2_000550
67. Riluzole [mart.]
68. Biomol-nt_000245
69. Riluzole [usp-rs]
70. Riluzole [who-dd]
71. Cid_5070
72. Riluzole (jan/usp/inn)
73. Riluzole [ema Epar]
74. Lopac0_001064
75. Schembl78905
76. Bspbio_000033
77. Bidd:gt0055
78. Spbio_000599
79. Spbio_001954
80. Riluzole [orange Book]
81. Bpbio1_000037
82. Bpbio1_000837
83. Gtpl2326
84. Zinc6481
85. Riluzole [usp Impurity]
86. Dtxsid3045192
87. Riluzole [usp Monograph]
88. Bdbm30705
89. Bio1_000416
90. Bio1_000905
91. Bio1_001394
92. Hms1773g08
93. Hms2089o19
94. Hms2094g07
95. Hms2233e14
96. Hms3263e10
97. Hms3371a09
98. Hms3657e13
99. Pharmakon1600-01505348
100. Amy14166
101. Bcp02142
102. Hy-b0211
103. Riluzole - Cas 1744-22-5
104. Tiglutik (thickened Oral Suspension)
105. Tox21_110252
106. Tox21_501064
107. Ac-730
108. Bbl013272
109. Ccg-39528
110. Nsc753433
111. Nsc759823
112. S1614
113. Stk503686
114. Akos000265071
115. Tox21_110252_1
116. Db00740
117. Ks-5231
118. Lp01064
119. Nsc 753433
120. Nsc 759823
121. Sdccgsbi-0051034.p003
122. 2-amino-6-trifluoromethoxy-benzothiazole
123. 6-trifluoromethoxy-2-amino-benzothiazole
124. Ncgc00015882-01
125. Ncgc00015882-02
126. Ncgc00015882-03
127. Ncgc00015882-04
128. Ncgc00015882-05
129. Ncgc00015882-06
130. Ncgc00015882-07
131. Ncgc00015882-08
132. Ncgc00015882-10
133. Ncgc00015882-11
134. Ncgc00015882-12
135. Ncgc00015882-13
136. Ncgc00015882-15
137. Ncgc00015882-28
138. Ncgc00023141-02
139. Ncgc00023141-04
140. Ncgc00023141-05
141. Ncgc00023141-06
142. Ncgc00261749-01
143. 6-(trifluoromethoxy)-2-aminobenzothiazole
144. 6-trifluoromethoxybenzo[d]thiazol-2-amine
145. Br164340
146. Sbi-0051034.p002
147. 2-amino-6-(trifluoromethoxy) Benzothiazole
148. Db-030335
149. Eu-0101064
150. Ft-0611194
151. R1174
152. Sw196805-4
153. En300-23782
154. 6-trifluoromethoxy-1,3-benzothiazol-2-ylamine
155. C07937
156. D00775
157. Vu0239571-11
158. 744r225
159. Q415744
160. Sr-01000002997-3
161. Brd-k21283037-001-02-5
162. Brd-k21283037-003-03-9
163. Brd-k21283037-003-06-2
164. F3282-0020
165. Z166605314
166. Riluzole, United States Pharmacopeia (usp) Reference Standard
167. 2-amino-6-(trifluoromethoxy)-1,3-benzothiazole;2-amino-6-(trifluoromethoxy)benzothiazole
| Molecular Weight | 234.20 g/mol |
|---|---|
| Molecular Formula | C8H5F3N2OS |
| XLogP3 | 3.6 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 1 |
| Exact Mass | 234.00746845 g/mol |
| Monoisotopic Mass | 234.00746845 g/mol |
| Topological Polar Surface Area | 76.4 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 238 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 4 | |
|---|---|
| Drug Name | Rilutek |
| PubMed Health | Riluzole (By mouth) |
| Drug Classes | Central Nervous System Agent |
| Drug Label | RILUTEK (riluzole) is a member of the benzothiazole class. Chemically, riluzole is 2-amino-6-(trifluoromethoxy)benzothiazole. Its molecular formula is C8H5F3N2OS and its molecular weight is 234.2. Its structural formula is as follows:Riluzole is a... |
| Active Ingredient | Riluzole |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Covis Pharma Sarl |
| 2 of 4 | |
|---|---|
| Drug Name | Riluzole |
| PubMed Health | Riluzole (By mouth) |
| Drug Classes | Central Nervous System Agent |
| Drug Label | RILUTEK (riluzole) is a member of the benzothiazole class. Chemically, riluzole is 2-amino-6-(trifluoromethoxy)benzothiazole. Its molecular formula is C8H5F3N2OS and its molecular weight is 234.2. Its structural formula is as follows:Riluzole is a... |
| Active Ingredient | Riluzole |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Mylan Pharms; Apotex; Sun Pharm Inds; Glenmark Generics; Impax Labs |
| 3 of 4 | |
|---|---|
| Drug Name | Rilutek |
| PubMed Health | Riluzole (By mouth) |
| Drug Classes | Central Nervous System Agent |
| Drug Label | RILUTEK (riluzole) is a member of the benzothiazole class. Chemically, riluzole is 2-amino-6-(trifluoromethoxy)benzothiazole. Its molecular formula is C8H5F3N2OS and its molecular weight is 234.2. Its structural formula is as follows:Riluzole is a... |
| Active Ingredient | Riluzole |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Covis Pharma Sarl |
| 4 of 4 | |
|---|---|
| Drug Name | Riluzole |
| PubMed Health | Riluzole (By mouth) |
| Drug Classes | Central Nervous System Agent |
| Drug Label | RILUTEK (riluzole) is a member of the benzothiazole class. Chemically, riluzole is 2-amino-6-(trifluoromethoxy)benzothiazole. Its molecular formula is C8H5F3N2OS and its molecular weight is 234.2. Its structural formula is as follows:Riluzole is a... |
| Active Ingredient | Riluzole |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Mylan Pharms; Apotex; Sun Pharm Inds; Glenmark Generics; Impax Labs |
For the treatment of amyotrophic lateral sclerosis (ALS, Lou Gehrig's Disease)
FDA Label
Investigated for use/treatment in atopic dermatitis.
Rilutek is indicated to extend life or the time to mechanical ventilation for patients with amyotrophic lateral sclerosis (ALS).
Clinical trials have demonstrated that Rilutek extends survival for patients with ALS.
Survival was defined as patients who were alive, not intubated for mechanical ventilation and tracheotomy-free.
There is no evidence that Rilutek exerts a therapeutic effect on motor function, lung function, fasciculations, muscle strength and motor symptoms.
Rilutek has not been shown to be effective in the late stages of ALS.
Safety and efficacy of Rilutek has only been studied in ALS. Therefore, Rilutek should not be used in patients with any other form of motor-neurone disease.
Riluzole, a member of the benzothiazole class, is indicated for the treatment of patients with amyotrophic lateral sclerosis (ALS). Riluzole extends survival and/or time to tracheostomy. It is also neuroprotective in various in vivo experimental models of neuronal injury involving excitotoxic mechanisms. The etiology and pathogenesis of amyotrophic lateral sclerosis (ALS) are not known, although a number of hypotheses have been advanced. One hypothesis is that motor neurons, made vulnerable through either genetic predisposition or environmental factors, are injured by glutamate. In some cases of familial ALS the enzyme superoxide dismutase has been found to be defective.
BF-37 interferes directly with cellular processes of the immune system of the skin, thereby diminishing the inflammation that underlies the reddening and itching.
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
Excitatory Amino Acid Antagonists
Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)
Neuroprotective Agents
Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)
N07XX02
N07XX02
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
N - Nervous system
N07 - Other nervous system drugs
N07X - Other nervous system drugs
N07XX - Other nervous system drugs
N07XX02 - Riluzole
Absorption
Riluzole is well-absorbed (approximately 90%), with average absolute oral bioavailability of about 60% (CV=30%). A high fat meal decreases absorption, reducing AUC by about 20% and peak blood levels by about 45%.
Riluzole is extensively metabolized to six major and a number of minor metabolites, which have not all been identified to date. Metabolism is mostly hepatic, consisting of cytochrome P450–dependent hydroxylation and glucuronidation. CYP1A2 is the primary isozyme involved in N-hydroxylation; CYP2D6, CYP2C19, CYP3A4, and CYP2E1 are considered unlikely to contribute significantly to riluzole metabolism in humans.
Riluzole has known human metabolites that include 4-hydroxy-riluzole, 5-hydroxy-riluzole, 7-hydroxy-riluzole, and N-Hydroxyriluzole.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
The mean elimination half-life of riluzole is 12 hours (CV=35%) after repeated doses.
The mode of action of riluzole is unknown. Its pharmacological properties include the following, some of which may be related to its effect: 1) an inhibitory effect on glutamate release (activation of glutamate reuptake), 2) inactivation of voltage-dependent sodium channels, and 3) ability to interfere with intracellular events that follow transmitter binding at excitatory amino acid receptors.
BF-37 inhibits the proliferation of T-cells. An increased proliferation of these immune cells is believed to cause atopic dermatitis. Biofrontera assumes that BF-37 interferes directly with cellular processes of the immune systems of the skin, thereby diminishing the inflammation that underlines the reddening and itching.
API SUPPLIERS
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
NDC Package Code : 63278-1076
Start Marketing Date : 1996-12-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Kookjeon Pharmaceutical Co., Ltd.
Registration Date : 2013-12-19
Registration Number : Number 4749-12-ND
Manufacturer Name : Farmak, as
Manufacturer Address : Na vlcinci 16/3, Klasterni Hradisko, 779 00 Olomouc, Czech Republic
| Available Reg Filing : ASMF |
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
Registrant Name : Sanofi-Aventis Korea Co., Ltd.
Registration Date : 2012-08-31
Registration Number : 3025-5-ND
Manufacturer Name : EUROAPI FRANCE
Manufacturer Address : 4 La Paterie, 63480, Vertolaye, France
| Available Reg Filing : ROW |
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-02-07
Pay. Date : 2013-04-08
DMF Number : 26147
Submission : 2012-06-08
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23215
Submission : 2009-10-26
Status : Active
Type : II
Date of Issue : 2022-07-04
Valid Till : 2025-07-03
Written Confirmation Number : WC-0040
Address of the Firm :
NDC Package Code : 65977-0045
Start Marketing Date : 1995-12-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-11-12
Pay. Date : 2013-07-10
DMF Number : 24693
Submission : 2011-02-28
Status : Active
Type : II
Registration Number : 224MF10021
Registrant's Address : Torre Esteve, Pg. de la Zona Franca, 109, 4th floor, 08038 Barcelona - Spain
Initial Date of Registration : 2012-02-01
Latest Date of Registration : --
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22107
Submission : 2008-10-22
Status : Active
Type : II
Date of Issue : 2022-06-07
Valid Till : 2025-06-25
Written Confirmation Number : WC-0057n
Address of the Firm :
NDC Package Code : 66039-812
Start Marketing Date : 2008-10-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : Mpeak Korea Co., Ltd.
Registration Date : 2013-05-16
Registration Number : Number 4692-8-ND
Manufacturer Name : Glenmark Life Sciences Limited
Manufacturer Address : Plot No. 3109, GIDC Industrial Estate, Ankleshwar - 393 002, Dist: Bharuch, Gujarat State, India
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22438
Submission : 2009-03-16
Status : Active
Type : II
Date of Issue : 2019-07-15
Valid Till : 2022-07-14
Written Confirmation Number : WC-0168
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25260
Submission : 2011-09-24
Status : Active
Type : II
Date of Issue : 2022-09-30
Valid Till : 2025-06-05
Written Confirmation Number : WC-0370
Address of the Firm :
GDUFA
DMF Review : Reviewed
Rev. Date : 2023-02-23
Pay. Date : 2021-10-28
DMF Number : 15252
Submission : 2001-01-16
Status : Active
Type : II
NDC Package Code : 65129-1011
Start Marketing Date : 2013-12-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Registrant Name : SK Chemicals Co., Ltd.
Registration Date : 2021-05-14
Registration Number : Number 703-7-ND
Manufacturer Name : ScinoPharm Taiwan, Ltd.
Manufacturer Address : No. 1, Nan-Ke 8th Road, Shan-Hua, Tainan 74144, Taiwan
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 25260
Submission : 2011-09-24
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22596
Submission : 2009-03-05
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2013-11-12
Pay. Date : 2013-07-10
DMF Number : 24693
Submission : 2011-02-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22107
Submission : 2008-10-22
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23215
Submission : 2009-10-26
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-02-23
Pay. Date : 2021-10-28
DMF Number : 15252
Submission : 2001-01-16
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-02-07
Pay. Date : 2013-04-08
DMF Number : 26147
Submission : 2012-06-08
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22438
Submission : 2009-03-16
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
JDMF
Registration Number : 224MF10021
Registrant's Address : Torre Esteve, Pg. de la Zona Franca, 109, 4th floor, 08038 Barcelona - Spain
Initial Date of Registration : 2012-02-01
Latest Date of Registration : 2012-02-01
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
Date of Issue : 2022-09-30
Valid Till : 2025-06-05
Written Confirmation Number : WC-0370
Address of the Firm : Plot No. 289-290 G.I.D.C Ankleshwar, Bharuch, Gujarat.
Date of Issue : 2020-06-28
Valid Till : 2022-06-05
Written Confirmation Number : WC-0370A3
Address of the Firm : Plot No. 289-290 G.I.D.C Ankleshwar, Bharuch, Gujarat, India
Date of Issue : 2014-03-06
Valid Till : 2016-07-02
Written Confirmation Number : WC-0128
Address of the Firm : 1A, Bommasandra Industrial Area, 4th Phase,Bommasandra Industrial Estate (Post O...
Date of Issue : 2022-06-07
Valid Till : 2025-06-25
Written Confirmation Number : WC-0057n
Address of the Firm : Plot No. 3109, GIDC, Industrial Estate, Ankleshwar-393 002, Bharuch, Gujarat
Date of Issue : 2021-01-08
Valid Till : 2023-11-23
Written Confirmation Number : WC-0310
Address of the Firm : Plot No.Z-103/I Dahej Sez, Phase-II Dahej, Dist Bharuch, Gujarat
Date of Issue : 2022-07-04
Valid Till : 2025-07-03
Written Confirmation Number : WC-0040
Address of the Firm : Unit-I, Survey No.213, 214 & 255, Bonthapally Village, Jinnaram Mandal, Medak ...
Date of Issue : 2019-07-15
Valid Till : 2022-07-14
Written Confirmation Number : WC-0168
Address of the Firm : Plot No.24/2 & 25, Phase-IV, GIDC, Industrial Zone, Panoli-394 116, Dist-Bharuch
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]KDMF
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
Registrant Name : Kookjeon Pharmaceutical Co., Ltd.
Registration Date : 2013-12-19
Registration Number : Number 4749-12-ND
Manufacturer Name : Farmak, as
Manufacturer Address : Na vlcinci 16/3, Klasterni Hradisko, 779 00 Olomouc, Czech Republic
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
Registrant Name : Sanofi-Aventis Korea Co., Ltd.
Registration Date : 2008-05-07
Registration Number : 3025-2-ND
Manufacturer Name : Sanofi Chimie
Manufacturer Address : Center de production de Vitry-sur-Seine9, Quai Jules Guesde 94403 Vitry SUR Seine Ced...
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
Registrant Name : Sanofi-Aventis Korea Co., Ltd.
Registration Date : 2012-08-31
Registration Number : 3025-5-ND
Manufacturer Name : EUROAPI FRANCE
Manufacturer Address : 4 La Paterie, 63480, Vertolaye, France
Registrant Name : Mpeak Korea Co., Ltd.
Registration Date : 2013-05-16
Registration Number : Number 4692-8-ND
Manufacturer Name : Glenmark Life Sciences Limit...
Manufacturer Address : Plot No. 3109, GIDC Industrial Estate, Ankleshwar - 393 002, Dist: Bharuch, Gujarat S...
Registrant Name : SK Chemicals Co., Ltd.
Registration Date : 2021-05-14
Registration Number : Number 703-7-ND
Manufacturer Name : ScinoPharm Taiwan, Ltd.
Manufacturer Address : No. 1, Nan-Ke 8th Road, Shan-Hua, Tainan 74144, Taiwan
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
NDC Package Code : 63278-1076
Start Marketing Date : 1996-12-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 66039-812
Start Marketing Date : 2008-10-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0045
Start Marketing Date : 1995-12-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65129-1011
Start Marketing Date : 2013-12-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54871-1098
Start Marketing Date : 2024-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
About the Company : Farmak, A.S. is a privately held chemical and pharmaceutical company based in the Czech Republic. It specializes in researching, developing and producing active pharmaceutical ingr...
EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
About the Company : EUROAPI is the market leader in small molecule APIs with projected sales of about €1 billion in 2022. With around 200 APIs, it has one of the largest portfolios in the market. Th...
Faran Shimi: Leading producer of high-quality APIs & alkaloid opiates, serving major pharmaceutical companies across the Middle East.
About the Company : Faran Shimi Pharmaceutical Company, established in 2001 and affiliated with Golrang Pharmaceutical Investment Co, manufactures high-quality Active Pharmaceutical Ingredients (APIs)...
About the Company : Back in the year 1973, a team of individuals came up with such an idea – The idea called Alkem. Looking back at our 5 decades, illustrious journey, that one small idea has Not on...
About the Company : Apotex Pharmachem is a global fully integrated API R&D and manufacturing organization with its headquarters located in Brantford, Ontario, Canada and is a member of the Apotex grou...
About the Company : In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territo...
About the Company : Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Our branded generics business has a significant presence in mark...
About the Company : Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & F...
About the Company : Nhwa is specialized in manufacturing APIs and dosages in the field of Central Nervous System. With 40 years of experience and excellent reputation, Nhwa has become the leader of ma...
About the Company : ScinoPharm Taiwan Ltd. is a leading process R&D and API manufacturing service provider to the global pharmaceutical industry. With cGMP production facilities, ScinoPharm offers a w...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - TABLET;ORAL - 50MG
USFDA APPLICATION NUMBER - 20599
DOSAGE - FILM;ORAL - 50MG
USFDA APPLICATION NUMBER - 212640
Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seqens
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Jai Radhe Sales
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Welltone Material Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ulanqab Kema New Material
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Coating Systems & Additives
Fillers, Diluents & Binders
Controlled & Modified Release
Thickeners and Stabilizers
Direct Compression
Lubricants & Glidants
Disintegrants & Superdisintegrants
Film Formers & Plasticizers
Co-Processed Excipients
Granulation
Topical
Solubilizers
Empty Capsules
API Stability Enhancers
Emulsifying Agents
Rheology Modifiers
Vegetarian Capsules
Taste Masking
Coloring Agents
Chewable & Orodispersible Aids
Parenteral
Surfactant & Foaming Agents
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?
Market Place
